Insecticides (India) Ltd (NSE:INSECTICID)
₹ 647.7 -2.95 (-0.45%) Market Cap: 18.77 Bil Enterprise Value: 19.42 Bil PE Ratio: 13.46 PB Ratio: 1.54 GF Score: 91/100

Q4 2025 Insecticides (India) Ltd Earnings Call Transcript

May 28, 2025 / 11:30AM GMT
Release Date Price: ₹830.25 (+1.61%)

Key Points

Positve
  • Insecticides (India) Ltd (BOM:532851) reported a strong revenue growth of 32% in Q4 FY25, driven by premium products and new launches.
  • The company successfully launched 12 new products in FY25, with plans to launch six more in FY26, indicating a robust product pipeline.
  • Gross profit margin improved to 52%, showing a 655 basis points increase over the previous year, attributed to better product mix and pricing strategy.
  • The company has received government approval for a new plant, expected to contribute significantly to production and revenue growth.
  • Insecticides (India) Ltd (BOM:532851) is expanding its presence in the international market, with ongoing investments in product registrations across various countries.
Negative
  • The company experienced an 8% decline in average prices during the year, impacting overall growth despite volume increases.
  • There are concerns about potential manpower shortages affecting production, particularly due to geopolitical tensions.
  • The working capital has increased due to inventory buildup, which is a temporary measure but could impact cash flow management.
  • Despite strong growth, the company remains heavily reliant on the domestic market, with only 5% of revenue coming from exports.
  • There is uncertainty regarding the impact of international tariffs and competition, particularly from China, which could affect pricing and market dynamics.
Operator

Ladies and gentlemen, good day and welcome to Insecticides India Limited Q4 FY25 earnings conference call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to [Marsum Lateria].

Thank you and over to you, ma'am.

Unidentified Company Representative

Thank you, and welcome to Q4 FY25 earnings concall of Insecticides India Limited. Today, on this call, we have with us Mr. Rajesh Kumar Aggarwal, the Managing Director; Mr. Sandeep Aggarwal, the Chief Financial Officer; and Mr. Dushyant Sood, the Chief Market Officer.

Before we proceed the call, I would like to give a small disclaimer that this conference may contain certain forward-looking statements which are based on beliefs, opinions, and expectations of the company as on date. Now, I would like to hand over the call to Mr. Rajesh for his opening remarks. Over to you, sir.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot